The tumor-promoting activities of CDC20 were reported in many tumors including pancreatic ductal adenocarcinoma [59], lung adenocarcinoma [60], gastric cancer [61], breast cancer [62, 63] and bladder cancer [64]. This evidence concerns the gene CDC20 and pancreatic ductal adenocarcinoma.